Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, R | - |
dc.contributor.author | Jun, YJ | - |
dc.contributor.author | Kim, JI | - |
dc.contributor.author | Jin, C | - |
dc.contributor.author | Sohn, YS | - |
dc.date.accessioned | 2024-01-21T04:42:15Z | - |
dc.date.available | 2024-01-21T04:42:15Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2005-06-20 | - |
dc.identifier.issn | 0168-3659 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/136356 | - |
dc.description.abstract | A new amphiphilic poly(organophosphazene) was synthesized by stepwise nucleophilic substitutions with a hydrophilic methoxy poly(ethylene glycol) with an average molecular weight of 350 (MPEG350) and a hydrophobic glyCyl-L-glutamate as side groups, and then an antitumor (dach)platinum(II) (dach: trans -(+/-)- 1,2-diaminocyclohexane) moiety was conjugated to the polymer using the dipeptide as a spacer. This polymeric platinum conjugate was found to be accumulated in the tumor tissue to a remarkably greater extent than in the normal tissue (tumor/tissue ratio > 4), probably due to the excellent EPR effect and the long circulating properties of the polymer conjugate (t(1/2 beta)=6.2 h and AUC=4020 nmol h/ml) compared with carboplatin ((1/2 beta) =0.42 h and AUC=120 nmol h/ml). The polymer conjugate also exhibited high in vitro cytotoxicity comparable to cisplatin against several human tumor cells tested. (c) 2005 Elsevier B.V. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | VASCULAR-PERMEABILITY | - |
dc.subject | ANTITUMOR-ACTIVITY | - |
dc.subject | MOLECULAR-WEIGHT | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | LIPOSOME SIZE | - |
dc.subject | COMPLEXES | - |
dc.subject | POLYMERS | - |
dc.subject | BIODISTRIBUTION | - |
dc.subject | ELECTROLYTES | - |
dc.subject | THERAPEUTICS | - |
dc.title | Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jconrel.2005.03.016 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CONTROLLED RELEASE, v.105, no.1-2, pp.142 - 150 | - |
dc.citation.title | JOURNAL OF CONTROLLED RELEASE | - |
dc.citation.volume | 105 | - |
dc.citation.number | 1-2 | - |
dc.citation.startPage | 142 | - |
dc.citation.endPage | 150 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000230576600013 | - |
dc.identifier.scopusid | 2-s2.0-20444427224 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | VASCULAR-PERMEABILITY | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | MOLECULAR-WEIGHT | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | LIPOSOME SIZE | - |
dc.subject.keywordPlus | COMPLEXES | - |
dc.subject.keywordPlus | POLYMERS | - |
dc.subject.keywordPlus | BIODISTRIBUTION | - |
dc.subject.keywordPlus | ELECTROLYTES | - |
dc.subject.keywordPlus | THERAPEUTICS | - |
dc.subject.keywordAuthor | polyphosphazene | - |
dc.subject.keywordAuthor | platinum conjugate | - |
dc.subject.keywordAuthor | anticancer drug | - |
dc.subject.keywordAuthor | tumor selectivity | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.